PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
3364571-0	1988	Stimulation of taurocholate and glycocholate efflux from the rat hepatocyte by arginine vasopressin.	Taurocholic Acid	15-27	arginine vasopressin	Rattus norvegicus	88-99	
3364571-1	1988	Vasopressin induces alterations in the transmembrane distribution of the bile salts taurocholate and glycocholate but not of cholate, chenodeoxycholate, or chenodeoxycholate derivatives in isolated rat hepatocytes in suspension.	Taurocholic Acid	84-96	arginine vasopressin	Rattus norvegicus	0-11	
3364571-6	1988	At half-maximal effective concentrations, arginine vasopressin increases unidirectional efflux of taurocholate by 34% (EC50 = 1.5 X 10(-9) M) and glycocholate by 17% (EC50 = 5 X 10(-9) M).	Taurocholic Acid	98-110	arginine vasopressin	Rattus norvegicus	51-62	
3364571-7	1988	In the presence of 0.05 microM arginine vasopressin, the apparent Km value for taurocholate efflux decreases from 1.57 mM (control) to 0.94 mM; for glycocholate, the apparent Km decreases from 5.19 mM (control) to 3.22 mM.	Taurocholic Acid	79-91	arginine vasopressin	Rattus norvegicus	40-51	
2138086-2	1990	At a concentration ratio of 5:1 (antagonist to hormone), the V1 vasopressin antagonist, (dCH2)5Tyr(Me)AVP, inhibits the vasopressin induced efflux of taurocholate by approximately 82%, and of glycocholate, by approximately 85%.	Taurocholic Acid	150-162	arginine vasopressin	Rattus norvegicus	64-75	
8020886-4	1994	Vasopressin (10(-9) mol/L), a hormone known to activate protein kinase C, and phorbol-12,13-dibutyrate (10(-5) mol/L) significantly inhibited the glucagon-stimulated increase in taurocholate uptake rate (72% +/- 10% and 105% +/- 13% inhibition, respectively).	Taurocholic Acid	178-190	arginine vasopressin	Rattus norvegicus	0-11	
8020886-8	1994	Vasopressin and phorbol-12,13-dibutyrate suppression of glucagon-stimulated taurocholate uptake rate was not accompanied by diminished cyclic AMP levels.	Taurocholic Acid	76-88	arginine vasopressin	Rattus norvegicus	0-11	
8020886-9	1994	Moreover, vasopressin and phorbol-12,13-dibutyrate inhibited dibutyryl cyclic AMP-stimulated taurocholate uptake rate can be dissociated from alterations in the cyclic AMP levels.	Taurocholic Acid	93-105	arginine vasopressin	Rattus norvegicus	10-21	
2138086-1	1990	The peptide hormone, arginine-vasopressin[( Arg8]vasopressin, AVP), stimulates efflux of the bile salts taurocholate and glycocholate from the rat hepatocyte in suspension via its association with the V1 receptor on the hepatic cell membrane.	Taurocholic Acid	104-116	arginine vasopressin	Rattus norvegicus	30-41	
2138086-1	1990	The peptide hormone, arginine-vasopressin[( Arg8]vasopressin, AVP), stimulates efflux of the bile salts taurocholate and glycocholate from the rat hepatocyte in suspension via its association with the V1 receptor on the hepatic cell membrane.	Taurocholic Acid	104-116	arginine vasopressin	Rattus norvegicus	49-60	
2138086-1	1990	The peptide hormone, arginine-vasopressin[( Arg8]vasopressin, AVP), stimulates efflux of the bile salts taurocholate and glycocholate from the rat hepatocyte in suspension via its association with the V1 receptor on the hepatic cell membrane.	Taurocholic Acid	104-116	arginine vasopressin	Rattus norvegicus	62-65	
6142855-0	1984	Induction of taurocholate release from isolated rat hepatocytes in suspension by alpha-adrenergic agents and vasopressin: implications for control of bile salt secretion.	Taurocholic Acid	13-25	arginine vasopressin	Rattus norvegicus	109-120	
8020886-0	1994	Vasopressin and phorbol-12,13-dibutyrate inhibit glucagon- or cyclic AMP-stimulated taurocholate uptake in isolated rat hepatocytes.	Taurocholic Acid	84-96	arginine vasopressin	Rattus norvegicus	0-11	
1702935-4	1991	When TC was infused and paracellular permeability increased with VP, neither bile flow nor TC output changed, whereas outputs of cations fell.	Taurocholic Acid	5-7	arginine vasopressin	Rattus norvegicus	65-67	
2138086-2	1990	At a concentration ratio of 5:1 (antagonist to hormone), the V1 vasopressin antagonist, (dCH2)5Tyr(Me)AVP, inhibits the vasopressin induced efflux of taurocholate by approximately 82%, and of glycocholate, by approximately 85%.	Taurocholic Acid	150-162	arginine vasopressin	Rattus norvegicus	102-105	
2138086-2	1990	At a concentration ratio of 5:1 (antagonist to hormone), the V1 vasopressin antagonist, (dCH2)5Tyr(Me)AVP, inhibits the vasopressin induced efflux of taurocholate by approximately 82%, and of glycocholate, by approximately 85%.	Taurocholic Acid	150-162	arginine vasopressin	Rattus norvegicus	120-131	
2138086-5	1990	A more gradual and prolonged increase in [14C]taurocholate secretion, reflecting an increased biliary concentration of [14C]taurocholate, is observed beginning 6 min after vasopressin, reaching a plateau of 23 +/- 12% over baseline by 14 min and returning to baseline by 30 min.	Taurocholic Acid	46-58	arginine vasopressin	Rattus norvegicus	172-183